ATE465752T1 - Verfahren zur gewinnung delipidierter antigener aggregate von hepatitis b und deren verwendung - Google Patents

Verfahren zur gewinnung delipidierter antigener aggregate von hepatitis b und deren verwendung

Info

Publication number
ATE465752T1
ATE465752T1 AT01998363T AT01998363T ATE465752T1 AT E465752 T1 ATE465752 T1 AT E465752T1 AT 01998363 T AT01998363 T AT 01998363T AT 01998363 T AT01998363 T AT 01998363T AT E465752 T1 ATE465752 T1 AT E465752T1
Authority
AT
Austria
Prior art keywords
delipidated
hepatitis
obtaining
antigen aggregates
aggregates
Prior art date
Application number
AT01998363T
Other languages
English (en)
Inventor
Rubido Julio Aguilar
Arias Eduardo Penton
Dina Tleugulova
Mensies Minerva Sewer
Gonzalez Verena Muzio
Nenieto Gerardo Guill
Bernard Iloki Simon
Ricondo Luis Cruz
Cama Viviana Falcon
Hernandez Yanet Tambara
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE465752T1 publication Critical patent/ATE465752T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT01998363T 2000-12-01 2001-11-29 Verfahren zur gewinnung delipidierter antigener aggregate von hepatitis b und deren verwendung ATE465752T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20000279A CU23002A1 (es) 2000-12-01 2000-12-01 Método de obtención de agregados antigénicos y su uso en formulaciones
PCT/CU2001/000009 WO2002043756A2 (es) 2000-12-01 2001-11-29 Método de obtención de agregados antigénicos y su uso en formulaciones

Publications (1)

Publication Number Publication Date
ATE465752T1 true ATE465752T1 (de) 2010-05-15

Family

ID=5459569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01998363T ATE465752T1 (de) 2000-12-01 2001-11-29 Verfahren zur gewinnung delipidierter antigener aggregate von hepatitis b und deren verwendung

Country Status (17)

Country Link
US (2) US20040202676A1 (de)
EP (1) EP1346727B1 (de)
JP (1) JP4974441B2 (de)
KR (1) KR100873675B1 (de)
CN (1) CN1253206C (de)
AR (1) AR031437A1 (de)
AT (1) ATE465752T1 (de)
AU (2) AU2002221518B2 (de)
BR (1) BRPI0115859B8 (de)
CA (1) CA2429543C (de)
CU (1) CU23002A1 (de)
DE (1) DE60141978D1 (de)
ES (1) ES2342150T3 (de)
PT (1) PT1346727E (de)
RU (1) RU2266754C2 (de)
WO (1) WO2002043756A2 (de)
ZA (1) ZA200303948B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23405A1 (es) * 2003-10-20 2009-08-04 Ct Ingenieria Genetica Biotech Composiciones farmacéuticas para uso terapéutico
EP1652914A1 (de) * 2004-10-27 2006-05-03 Berna Biotech AG Virosom Partikel, Influenzavirus und Hepatitis B Virus Antigenen enthaltend
PL1802746T3 (pl) 2004-10-27 2011-10-31 Crucell Switzerland Ag Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B
WO2007016130A2 (en) * 2005-07-27 2007-02-08 Lipid Sciences, Inc. A method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
CU23740A1 (es) * 2009-09-29 2011-12-28 Ct Ingenieria Genetica Biotech Método de obtención de una formulación de antígenos del virus de la hepatitis b
AR107262A1 (es) 2016-01-27 2018-04-11 Lilly Co Eli Inactivación de patógenos por delipidación
EA201892212A1 (ru) * 2016-03-31 2019-03-29 Сентро Де Инхеньерия Хенетика И Биотекнолохия Фармацевтическая композиция, которая включает поверхностные и нуклеокапсидные антигены вируса гепатита b

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
EP0231039B1 (de) * 1986-01-14 1992-01-08 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Verfahren zur Herstellung immunologischer Komplexe und diese enthaltende pharmazeutische Zusammensetzung
US5728804A (en) * 1995-06-02 1998-03-17 Research Corporation Technologies, Inc. Use of cyclodextrins for protein renaturation
ES2260235T3 (es) * 2000-06-22 2006-11-01 Ucb Pharma Limited Modificacion del antigeno "core" de la hepatitis b.
US8092734B2 (en) * 2004-05-13 2012-01-10 Aptina Imaging Corporation Covers for microelectronic imagers and methods for wafer-level packaging of microelectronics imagers

Also Published As

Publication number Publication date
KR100873675B1 (ko) 2008-12-11
CN1477972A (zh) 2004-02-25
PT1346727E (pt) 2010-05-21
BRPI0115859B8 (pt) 2021-05-25
CU23002A1 (es) 2004-11-18
AU2151802A (en) 2002-06-11
JP2004529861A (ja) 2004-09-30
AR031437A1 (es) 2003-09-24
WO2002043756A3 (es) 2003-01-09
US20090104223A1 (en) 2009-04-23
AU2002221518B2 (en) 2006-06-01
BRPI0115859B1 (pt) 2020-10-13
KR20030068161A (ko) 2003-08-19
EP1346727A2 (de) 2003-09-24
EP1346727B1 (de) 2010-04-28
RU2266754C2 (ru) 2005-12-27
CN1253206C (zh) 2006-04-26
BR0115859A (pt) 2003-12-30
CA2429543A1 (en) 2003-05-20
US20040202676A1 (en) 2004-10-14
ES2342150T3 (es) 2010-07-02
ZA200303948B (en) 2004-03-30
DE60141978D1 (de) 2010-06-10
CA2429543C (en) 2012-07-10
WO2002043756A2 (es) 2002-06-06
JP4974441B2 (ja) 2012-07-11

Similar Documents

Publication Publication Date Title
EP1283707A4 (de) Polymerisierbare zusammensetzungen und verfahren zur deren verwendung
DE69819332D1 (de) VERBESSERTE ANTIKÖRPER GEGEN IgE UND VERFAHREN ZUR VERBESSERUNG VON ANTIKÖRPERN
DE60117573D1 (de) Verschiedenartig gehärtete materialen und verfahren zur deren herstellung
DE60210794D1 (de) Rotor-stator apparat und verfahren zur bildung von partikeln
DE69916421D1 (de) Biochip und verfahren zur verwendung des biochips
DE60126156D1 (de) Verfahren und vorrichtung zur herstellung von knochenzement
DE50006193D1 (de) Verfahren zur herstellung von otoplastiken und otoplastik
DE60219139D1 (de) Vorrichtung und verfahren zur bildung von luftgelegten faserbahnen mit verbesserter gewichtseigenschaft
DE60115479D1 (de) Filter und verfahren zur kontrolle der abgasemissionen
DE69903497D1 (de) Verfahren und Vorrichtung zur Unterdrückung von Resonanz
DE60204740D1 (de) Hochintensitätsmischwerkzeug mit optimierten Stangen, Mischvorrichtung und Verfahren zur Tonermischungsverbesserung
DE60206897D1 (de) Verfahren zum Bewehren und Abdichten von Pflasteroberflächen
DE60042184D1 (de) Verfahren und Zusammensetzung zur Entschichtung von Photoresist
ATE432334T1 (de) Verfahren und zusammensetzung zur verbesserung der brenn- oder kraftstoffverbrennung
DE60220679D1 (de) Verfahren zur herstellung von dieselbrennstoff aus bitumen und synthesegas
DE60133816D1 (de) Stahlrohr zur verstärkung von automobilen und herstellungsverfahren dafür
DE50203769D1 (de) Vorrichtung und verfahren zur stabilitätsbestimmung von substanzen und formulierungen
DE60209608D1 (de) Verfahren und Vorrichtung zur Ermittlung von Strassenzuständen
DE60142485D1 (de) Verfahren zur Beurteilung von zellulären proliferativen Erkrankungen
DE60127546D1 (de) Verfahren und magnetische vorrichtung zur bestimmung der orientierung
DE50114195D1 (de) Verfahren und vorrichtung zur aufbereitung von formsand
DE50210643D1 (de) Anlage und verfahren zur herstellung von zementklinker
ATE465752T1 (de) Verfahren zur gewinnung delipidierter antigener aggregate von hepatitis b und deren verwendung
DE60210381D1 (de) Verfahren zur Registrierung einer Kennung und Photomaskensatz
DE60210879D1 (de) Verfahren zur Aufzeichnng einer Kennung und Photomaskensatz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1346727

Country of ref document: EP